Empower patients to manage their pregnancy and cancer risk through comprehensive genetic insights.​

Learn more about Myriad Genetics at the ACMG Annual Clinical Genetics Meeting

March 22-26; Exhibit Dates March 23-25
Nashville, TN; Booth 529

Schedule an appointment with us

Learn about advancements in polygenic risk scores (PRS) for all ancestries and prenatal screening to help enhance pregnancy risk management.

Exhibit:

  • Wednesday, March 23, 2022: 5:00 pm – 7:00 pm (Opening Reception in the Exhibit Hall)
  • Thursday, March 24, 2022: 9:30 am – 4:30 pm
  • Friday, March 25, 2022: 10:00 am – 1:00 pm

In person event: Nashville, TN (virtual option also available)










Myriad needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time by using the unsubscribe link or instructions in any email communications we send. For further information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.

Hidden Fields












Fetal fraction amplification with AMPLIFY™ technology

Fetal Fraction Amplification within NIPS Enables Detection of Clinically-relevant Genome-wide Copy-number Variants to 1Mb Resolution

Presented by:
Ashley Acevedo, PhD

Download now

Fetal fraction amplification within NIPS

A Tale of Two Hbs: DNA Sequencing and Hemoglobin Electrophoresis

Presented by:
Liz Collins, PhD, BSc

Download now

Fetal fraction amplification within NIPS

Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2

Presented by:
Thomas (T.J.) Slavin, MD, FACMG
Robert L. Reid, MD

Download now

Learn more about how Myriad helps you and your patients​

Our Tests

Help patients get ahead of cancer with our hereditary cancer test. View MyRisk gene panel table.

Identify couples at risk to pass down serious, prevalent, clinically-actionable inherited conditions.

Get reliable results the first time with noninvasive prenatal screening.

Recent Videos

Recent blog posts

The impact of prenatal screening on parents and pregnancies

There are many factors to consider when developing a genetic test or screen. Some common examples include sensitivity, specificity, cost, and…
Read more

The Year Ahead: Innovating and Growing in 2022 and Beyond

Eighteen months ago, we launched a bold transformation and growth plan for Myriad Genetics. The plan involved change in virtually every…
Read more

Even before birth, genetic screening provides insights for family planning

We at Myriad Genetics became champions of genetic testing and screening for a simple reason: to allow providers to empower patients…
Read more